A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

2020954 citationsJournal Articlegreen Open Access

Authors

Ventura Simonovich · Dr. Vitthalrao Vikhe Patil Foundation’s Medical College

Leandro Daniel Burgos Pratx · Dr. Vitthalrao Vikhe Patil Foundation’s Medical College

Paula Scibona · Dr. Vitthalrao Vikhe Patil Foundation’s Medical College

Maria Valeria Beruto · Dr. Vitthalrao Vikhe Patil Foundation’s Medical College

Marcelo Vallone · Dr. Vitthalrao Vikhe Patil Foundation’s Medical College

Carolina Vázquez · Dr. Vitthalrao Vikhe Patil Foundation’s Medical College

Abstract

No significant differences were observed in clinical status or overall mortality between patients treated with convalescent plasma and those who received placebo. (PlasmAr ClinicalTrials.gov number, NCT04383535.).

Topics & Keywords

COVID-19 Clinical Research Studies SARS-CoV-2 and COVID-19 Research Long-Term Effects of COVID-19

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 384, Issue 7, pp. 619-629

DOI: 10.1056/nejmoa2031304

Field-Weighted Citation Impact: 23.07